معرفی
Dr. Mina Xu is a Professor of Pathology and Laboratory Medicine at Yale School of Medicine, specializing in hematopathology and oncologic diagnostics. She directs Yale's Hematopathology division and Expert Consultation Practice, with affiliations spanning the Yale Cancer Center's genomics and immuno-oncology programs. Her research targets hematopoietic malignancies (leukemia, lymphoma, myeloma), biomarker discovery, and molecular diagnostics, utilizing cutting-edge techniques like spatial transcriptomics and AI-driven histopathology.
Research Focus: Dr. Xu's work bridges tumor immunology, diagnostic innovation, and translational medicine. Key interests include:
- Development of immunohistochemical biomarkers for myeloid/lymphoid neoplasms
- Machine learning applications in predicting lymphoma transformation
- Spatial multi-omics mapping in archival tissue samples
- Therapeutic response prediction in targeted cancer therapies
Recent Publications: Her 118+ articles (2023-2025) in journals like Nature Biotechnology and Blood demonstrate focus on: (1) Spatial transcriptomics for tumor microenvironments, (2) AI-enhanced diagnostic criteria, and (3) Novel biomarkers for hematologic malignancies. Trends show increasing integration of computational biology with clinical pathology.
Awards & Honors:
- American Society of Hematology Trainee Grant (2005)
- Westinghouse Science Award (1996)
- National Science Foundation Trainee Grant (1994)
- Weizmann Institute of Science Scholarship (1996)
Training & Collaboration: Actively mentors residents/fellows in pathology and collaborates with 13+ principal investigators, including Dr. Stephanie Halene (12 joint publications) and Dr. Amer Zeidan (9 joint publications). Research emphasizes team science within Yale Cancer Center consortia.
